Suppr超能文献

c-MET 信号通路概述。

An overview of the c-MET signaling pathway.

机构信息

Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Canada.

出版信息

Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S7-S19. doi: 10.1177/1758834011422556.

Abstract

c-MET is a receptor tyrosine kinase that, after binding with its ligand, hepatocyte growth factor, activates a wide range of different cellular signaling pathways, including those involved in proliferation, motility, migration and invasion. Although c-MET is important in the control of tissue homeostasis under normal physiological conditions, it has also been found to be aberrantly activated in human cancers via mutation, amplification or protein overexpression. This paper provides an overview of the c-MET signaling pathway, including its role in the development of cancers, and provides a rationale for targeting the pathway as a possible treatment option.

摘要

c-MET 是一种受体酪氨酸激酶,与配体肝细胞生长因子结合后,激活广泛的不同细胞信号通路,包括参与增殖、运动性、迁移和侵袭的信号通路。虽然 c-MET 在正常生理条件下控制组织动态平衡中很重要,但已经发现它在人类癌症中通过突变、扩增或蛋白过表达而异常激活。本文概述了 c-MET 信号通路,包括其在癌症发展中的作用,并为作为一种可能的治疗选择靶向该通路提供了理论依据。

相似文献

1
An overview of the c-MET signaling pathway.
Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S7-S19. doi: 10.1177/1758834011422556.
2
Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer.
Cancers (Basel). 2018 Aug 21;10(9):280. doi: 10.3390/cancers10090280.
3
C-MET as a new therapeutic target for the development of novel anticancer drugs.
Clin Transl Oncol. 2010 Apr;12(4):253-60. doi: 10.1007/s12094-010-0501-0.
6
Role of HGF/MET axis in resistance of lung cancer to contemporary management.
Transl Lung Cancer Res. 2012 Sep;1(3):179-93. doi: 10.3978/j.issn.2218-6751.2012.09.04.
8
c-MET as a potential therapeutic target and biomarker in cancer.
Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S21-35. doi: 10.1177/1758834011422557.

引用本文的文献

1
MAPK-targeted therapies in non-gastrointestinal stromal tumor soft tissue sarcomas: current landscape and future directions.
Front Oncol. 2025 Aug 20;15:1418537. doi: 10.3389/fonc.2025.1418537. eCollection 2025.
3
The pharmacokinetics of capmatinib and its efficacy in non-small cell lung cancer treatment: a narrative review.
Transl Lung Cancer Res. 2025 Jul 31;14(7):2842-2852. doi: 10.21037/tlcr-2025-700. Epub 2025 Jul 28.
5
Management of MET-Driven Resistance to Osimertinib in -Mutant Non-Small Cell Lung Cancer.
Genes (Basel). 2025 Jun 30;16(7):772. doi: 10.3390/genes16070772.
8
Advancements in Protein Kinase Inhibitors: From Discovery to Clinical Applications.
Research (Wash D C). 2025 Jun 21;8:0747. doi: 10.34133/research.0747. eCollection 2025.
9
Unique characteristics of autoantibodies targeting MET in patients with breast and lung cancer.
JCI Insight. 2025 May 22;10(10). doi: 10.1172/jci.insight.187392.
10
HHLA2 activates c-Met and identifies patients for targeted therapy in hepatocellular carcinoma.
J Exp Clin Cancer Res. 2025 May 20;44(1):153. doi: 10.1186/s13046-025-03407-6.

本文引用的文献

1
c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice.
Mol Biol Cell. 2011 Aug 1;22(15):2777-86. doi: 10.1091/mbc.E11-02-0134. Epub 2011 Jun 16.
2
Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
J Proteome Res. 2011 Jul 1;10(7):3200-11. doi: 10.1021/pr200238t. Epub 2011 Jun 9.
5
Ron kinase transphosphorylation sustains MET oncogene addiction.
Cancer Res. 2011 Mar 1;71(5):1945-55. doi: 10.1158/0008-5472.CAN-10-2100. Epub 2011 Jan 6.
6
Distinct interactions between c-Src and c-Met in mediating resistance to c-Src inhibition in head and neck cancer.
Clin Cancer Res. 2011 Feb 1;17(3):514-24. doi: 10.1158/1078-0432.CCR-10-1617. Epub 2010 Nov 24.
7
MET signalling: principles and functions in development, organ regeneration and cancer.
Nat Rev Mol Cell Biol. 2010 Dec;11(12):834-48. doi: 10.1038/nrm3012.
8
Inhibition of Src impairs the growth of met-addicted gastric tumors.
Clin Cancer Res. 2010 Aug 1;16(15):3933-43. doi: 10.1158/1078-0432.CCR-10-0106. Epub 2010 Jul 13.
10
Quantitative analysis of HGF and EGF-dependent phosphotyrosine signaling networks.
J Proteome Res. 2010 May 7;9(5):2734-42. doi: 10.1021/pr100145w.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验